Masimo (MASI) Cash from Discontinued Operations (2024 - 2026)
Masimo's (MASI) quarterly Cash from Discontinued Operations came in at 1500000.0 in Q2 2026, up 77.94% year-on-year from 842975.21 in Q2 2025, and down 850.0% quarter-over-quarter from 200000.0 in Q1 2026.
Masimo (MASI) Cash from Discontinued Operations (2024 - 2026) Analysis & Trends
Masimo's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 1500000.0 for Q2 2026.
- On a quarterly basis, Cash from Discontinued Operations rose 77.94% year-over-year to 1500000.0 in Q2 2026; TTM through Apr 2026 was 5900000.0, a 70.35% decrease from a year earlier, with the FY2026 full-year figure at 600000.0, down 98.23% from the prior year.
- Cash from Discontinued Operations fell to 1500000.0 in Q2 2026 per MASI's latest filing, from 200000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 23500000.0 in Q4 2024 and bottomed at 6800000.0 in Q1 2025.
- The 3-year median for Cash from Discontinued Operations is 200000.0 (2026), against an average of 3666666.67.
- Biggest YoY gain for Cash from Discontinued Operations was 84.62% in 2025; the steepest drop was 194.44% in 2025.
- Year by year, Cash from Discontinued Operations stood at 23500000.0 in 2024, then tumbled by 102.55% to 600000.0 in 2025, then sank by 150.0% to 1500000.0 in 2026.
- Per Business Quant, the three latest MASI Cash from Discontinued Operations figures stand at 1500000.0 (Q2 2026), 200000.0 (Q1 2026), and 600000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -1.50 Mn |
| Apr 4, 2026 | -1.50 Mn |
| Jan 3, 2026 | 200,000.00 |
| Jan 3, 2026 | 200,000.00 |
| Sep 27, 2025 | -600,000.00 |
| Sep 27, 2025 | -600,000.00 |
| Jun 28, 2025 | 7.80 Mn |
| Jun 28, 2025 | 7.80 Mn |
| Mar 29, 2025 | -6.80 Mn |
| Mar 29, 2025 | -6.80 Mn |
| Dec 28, 2024 | 23.50 Mn |
| Dec 28, 2024 | 23.50 Mn |
| Sep 28, 2024 | -3.90 Mn |
| Sep 28, 2024 | -3.90 Mn |
| Jun 29, 2024 | 7.10 Mn |
| Jun 29, 2024 | 7.10 Mn |
| Mar 30, 2024 | 7.20 Mn |
| Mar 30, 2024 | 7.20 Mn |